Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -217.73% is 46% below its 5-year average of -149.48%, around the middle of its 5-year range (-428.40%–-49.95%).
As of the fiscal period ended Tuesday, June 30, 2026. 11.23% above its 12-month average of -245.28%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -217.73%.
RETURN ON INVESTED CAPITAL (ROIC)
-217.73%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-245.28%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-205.96%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-149.48%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+11.23%
CURRENT VS 3Y AVG
-5.71%
CURRENT VS 5Y AVG
-45.66%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-33.87%
median of 687 covered companies
CURRENT VS SECTOR MEDIAN
-542.84%
vs the sector median at left
electroCore, Inc.
Market Cap
$93.22M
Return on Invested Capital (ROIC)
-217.73%
TTM Avg
-245.28%
3Y Avg
-205.96%
5Y Avg
-149.48%
Market Cap
$93.27M
Return on Invested Capital (ROIC)
-220.02%
TTM Avg
-209.28%
3Y Avg
-141.42%
5Y Avg
-99.57%
Market Cap
$93.80M
Return on Invested Capital (ROIC)
-4.43%
TTM Avg
2.86%
3Y Avg
2.48%
5Y Avg
2.48%
Market Cap
$91.68M
Return on Invested Capital (ROIC)
-216.05%
TTM Avg
-121.78%
3Y Avg
-79.31%
5Y Avg
-71.06%
Market Cap
$91.05M
Return on Invested Capital (ROIC)
-34.10%
TTM Avg
-61.58%
3Y Avg
-76.39%
5Y Avg
-65.18%
Market Cap
$90.54M
Return on Invested Capital (ROIC)
-24.40%
TTM Avg
-73.07%
3Y Avg
-65.09%
5Y Avg
-50.82%
Market Cap
$89.60M
Return on Invested Capital (ROIC)
-111.42%
TTM Avg
-65.09%
3Y Avg
-48.38%
5Y Avg
-36.92%
Market Cap
$88.48M
Return on Invested Capital (ROIC)
8.16%
TTM Avg
0.11%
3Y Avg
-4.79%
5Y Avg
-3.69%
Market Cap
$97.13M
Return on Invested Capital (ROIC)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| electroCore, Inc. (ECOR) | $93.22M | -217.73% | -245.28% | -205.96% | -149.48% |
| Biomea Fusion, Inc. (BMEA)vs › | $93.27M | -220.02% | -209.28% | -141.42% | -99.57% |
| Park Dental Partners, Inc. Common Stock (PARK)vs › | $93.80M | -4.43% | 2.86% | 2.48% | 2.48% |
| Neumora Therapeutics, Inc. Common Stock (NMRA)vs › | $91.68M | -216.05% | -121.78% | -79.31% | -71.06% |
| Equillium, Inc. (EQ)vs › | $91.05M | -34.10% | -61.58% | -76.39% | -65.18% |
| Rallybio Corporation (RLYB)vs › | $90.54M | -24.40% | -73.07% | -65.09% | -50.82% |
| PMV Pharmaceuticals, Inc. (PMVP)vs › | $89.60M | -111.42% | -65.09% | -48.38% | -36.92% |
| ImmuCell Corporation (ICCC)vs › | $88.48M | 8.16% | 0.11% | -4.79% | -3.69% |
| Conexeu Sciences Inc. (CNXU)vs › | $97.13M | N/A | N/A | N/A | N/A |
| Milestone Pharmaceuticals Inc. (MIST)vs › | $97.81M | -49.27% | -62.42% | -75.33% | -62.43% |
ROIC
-217.7%
ROE
N/A
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -217.73% |
| 2026-03-31 | -428.40% |
| 2025-12-31 | -179.71% |
| 2025-09-30 | -136.43% |
| 2025-06-30 | -264.12% |
| 2025-03-31 | -148.26% |
| 2024-12-31 | -107.45% |
| 2024-09-30 | -99.36% |
| 2024-06-30 | -96.17% |
| 2024-03-31 | -279.09% |
| 2023-12-31 | -241.50% |
| 2023-09-30 | -183.00% |
| 2023-06-30 | -296.30% |
| 2023-03-31 | -188.64% |
| 2022-12-31 | -129.15% |
| 2022-09-30 | -98.16% |
| 2022-06-30 | -74.93% |
| 2022-03-31 | -62.28% |
| 2021-12-31 | -53.66% |
| 2021-09-30 | -49.95% |
| 2021-06-30 | -83.78% |
| 2021-03-31 | -76.40% |
| 2020-12-31 | -95.41% |
| 2020-09-30 | -84.48% |
| 2020-06-30 | -138.54% |
| 2020-03-31 | -209.78% |
| 2019-12-31 | -174.39% |
| 2019-09-30 | -154.98% |
| 2019-06-30 | -128.52% |
| 2019-03-31 | -104.36% |
| 2018-12-31 | -82.12% |
| 2018-09-30 | -57.47% |
| 2018-06-30 | -41.61% |
| 2018-03-31 | -126.41% |
| 2017-12-31 | -77.44% |
